According to research reviewed by Gram, a small regulating molecule called microRNA-9-5p may help protect the heart from damage caused by repeated low blood sugar in diabetes. In a 2026 mouse study, boosting this molecule reduced heart inflammation and improved pumping strength, pointing to a possible future treatment target.
According to research reviewed by Gram, repeated episodes of very low blood sugar may injure the heart in people with diabetes, and a small molecule called microRNA-9-5p may help protect it. In a 2026 study of mice with type 2 diabetes, the researchers found that low blood sugar episodes lowered levels of this molecule in heart tissue. When they raised its levels, the mice showed less heart inflammation, fewer dying heart cells, and better pumping strength. When they lowered it further, the heart damage got worse. The results come from animal experiments, so they do not yet show that the same approach would work in people. Still, the findings point to a possible new target for future treatments that could reduce heart risks linked to aggressive blood sugar control.
Key Statistics
A 2026 mouse study published in Archives of Biochemistry and Biophysics found that boosting microRNA-9-5p reduced levels of the inflammation protein NLRP3 and improved heart pumping strength in diabetic mice with repeated low blood sugar.
The same 2026 study identified 16 small regulating molecules that were significantly lower in mice with repeated low blood sugar, and found a strong link of 0.82 between the protein ELAVL1 and the inflammation switch NLRP3.
In the 2026 study, blocking microRNA-9-5p made heart damage worse in diabetic mice, while boosting it reduced markers of cell death and inflammation in heart cells grown in the lab.
The Quick Take
- What they studied: Researchers asked whether repeated low blood sugar harms the heart in diabetes, and whether a tiny regulating molecule called microRNA-9-5p could protect heart cells from that damage.
- Who participated: The study used laboratory mice with type 2 diabetes, created by feeding them a high-fat diet and giving them a drug that damages insulin-producing cells. The exact number of mice was not stated in the summary. Heart cells grown in the lab were also tested.
- Key finding: Mice with repeated low blood sugar had more heart inflammation and weaker heart function. Their heart tissue also had lower levels of microRNA-9-5p, and 16 small regulating molecules were significantly lower overall. Boosting microRNA-9-5p reduced heart damage, while blocking it made damage worse.
- What it means for you: This is early laboratory and animal research, so it does not change how anyone should manage diabetes today. It does suggest that avoiding repeated severe low blood sugar episodes is important for heart health. Anyone with diabetes should talk with their doctor about safe blood sugar targets.
The Research Details
The researchers first gave mice a high-fat diet and a drug called streptozotocin to create a model of type 2 diabetes. They then caused repeated low blood sugar by giving the mice insulin again and again. This setup was designed to copy what can happen in people who work hard to keep their blood sugar tightly controlled.
To find the cause of heart damage, the team measured thousands of genes and small regulating molecules in heart tissue. They then used computer databases to predict which molecules control a known inflammation switch called NLRP3. This step narrowed the list to one protein, ELAVL1, and then to one microRNA, microRNA-9-5p, that appeared to act on it.
Next, the researchers tested these ideas in heart cells grown in the lab and in living mice. They increased or decreased microRNA-9-5p and measured inflammation, cell death, and heart pumping strength. The study used echocardiograms, which are heart ultrasounds, along with tissue staining and protein tests.
Using both lab-grown heart cells and living mice helps show whether a change seen in a dish also happens in a whole body. Testing a molecule by raising it, lowering it, and then reversing the effect with a second intervention makes it more likely that the link is real and not a coincidence. Combining gene measurements with computer predictions helped the team focus on a single candidate instead of guessing.
The study used several complementary methods, including direct binding tests, cell experiments, and animal experiments with rescue steps. Many of the key comparisons reported very small p-values, which suggests the differences were unlikely to be due to chance. However, the summary does not state how many mice were used, which makes it harder to judge the strength of the results. Because the work was done in mice and cells, the findings may not match human biology. The paper also notes that clinical validation in people is still needed.
What the Results Show
Mice with repeated low blood sugar lost weight and showed weaker heart function than diabetic mice that did not have these episodes. Their hearts also showed higher levels of proteins that drive inflammation and a form of cell death called pyroptosis. Gene testing found 42 genes that behaved differently between the two groups, with a clear link to the body’s inflammation alarm system.
The researchers identified ELAVL1, a protein that helps control how other genes are read, as a key partner of the NLRP3 inflammation switch. The link between the two was strong, with a correlation score of 0.82, where 1.0 would be a perfect match. Among the small regulating molecules, 16 were significantly lower in mice with repeated low blood sugar. Only one, microRNA-9-5p, was predicted to target ELAVL1 and was also clearly reduced.
When the team boosted microRNA-9-5p in heart cells, levels of ELAVL1, NLRP3, and a key inflammation enzyme dropped. The cells survived better and released less of a marker that signals cell damage. Blocking microRNA-9-5p produced the opposite effects, and these were reversed when ELAVL1 was also reduced. In living mice, boosting microRNA-9-5p improved heart pumping measures and lowered inflammatory signals, while blocking it worsened the damage.
The mice that received the microRNA-9-5p boost showed less clumping of NLRP3 with a partner protein called ASC, which is an early step in triggering inflammation. Levels of inflammatory messengers IL-1 beta and IL-18 also dropped. These findings support the idea that microRNA-9-5p works at more than one point in the inflammation chain. The weight loss seen in the low blood sugar mice also reflects the physical stress that repeated episodes place on the body.
Previous research has linked severe low blood sugar in people with diabetes to higher rates of heart problems and death, especially when blood sugar is pushed very low during intensive control. This study adds a possible molecular explanation by showing how low blood sugar may trigger inflammation inside heart cells. It also builds on growing evidence that small regulating molecules called microRNAs play a role in heart disease and inflammation.
The study was done in mice and in cells grown in the lab, so results may not translate directly to people. The summary does not state how many animals were used in each group, which limits how confidently the results can be judged. The microRNA was selected partly by computer predictions, which can miss important molecules or point to false matches. The study also does not show whether using microRNA-9-5p as a treatment would be safe or effective over the long term. The authors themselves note that clinical testing in patients with diabetes is still needed.
The Bottom Line
Based on this early research, the most reasonable conclusion is that avoiding repeated severe low blood sugar episodes is likely wise for heart health, since the study links these episodes to heart inflammation in mice. Confidence in the specific microRNA-9-5p treatment idea is low at this stage, because it has only been tested in mice and cells. No dosing or supplement advice can be drawn from this study. People with diabetes should follow their doctor’s blood sugar targets and discuss any concerns about hypoglycemia.
People with type 2 diabetes who take insulin or other medicines that can cause low blood sugar may find this research relevant to their long-term heart health. Doctors, diabetes educators, and researchers studying heart disease in diabetes may also find it useful. People without diabetes, or those who have never had low blood sugar episodes, should not change their habits based on this study alone.
This research is at an early stage, so no changes in treatment should be expected soon. Turning a laboratory finding like this into a tested medicine usually takes many years of animal and human trials. Anyone with diabetes who wants to reduce low blood sugar episodes can talk with their care team now, since that step does not depend on this study’s results.
Frequently Asked Questions
Can low blood sugar damage your heart if you have diabetes?
Research reviewed by Gram suggests repeated low blood sugar episodes may trigger heart inflammation and weaken heart function in diabetic mice. Severe lows have also been linked to higher rates of heart problems in people. Anyone with diabetes should discuss safe blood sugar targets with their doctor.
What is microRNA-9-5p and how could it help the heart?
MicroRNA-9-5p is a small molecule that helps control how other genes are used inside cells. In a 2026 mouse study, boosting it lowered inflammation and cell death in heart tissue. It is still being studied, and no treatment based on it is available for people yet.
Is there a treatment for heart damage from low blood sugar yet?
No approved treatment targets this pathway yet. The microRNA-9-5p finding comes from mice and lab-grown heart cells, so human testing would be needed first. Current advice focuses on preventing low blood sugar episodes through careful monitoring and medication review with a doctor.
How many mice were used in the microRNA-9-5p heart study?
The summary of this 2026 study in Archives of Biochemistry and Biophysics does not state the exact number of mice used. The researchers used diabetic mice with repeated low blood sugar, along with lab-grown heart cells, to test the role of microRNA-9-5p in heart inflammation.
Want to Apply This Research?
- Log every blood sugar reading below 70 mg/dL, noting the time, the cause if known, and any symptoms such as shakiness, sweating, or chest discomfort. Track the number of low episodes each week so trends are easy to see.
- Set a reminder to review low blood sugar patterns with your care team each month, and use the app to flag times of day or meals linked to lows. Ask your doctor whether your blood sugar targets are appropriate for your age and heart health.
- Over several months, track both low blood sugar episodes and any heart-related symptoms or measurements your doctor recommends, such as blood pressure and heart rate. Share these trends at regular appointments so your care team can adjust your plan safely.
This article summarizes an early laboratory and animal study and is for general information only. The research was done in mice and heart cells, so its findings may not apply to people. It is not medical advice. If you have diabetes or experience frequent low blood sugar, chest pain, or other heart symptoms, contact your doctor or healthcare provider. Do not change your medications or blood sugar plan based on this article without professional guidance.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.